Delphine Behr-roussel

Title: Delphine Behr-Roussel: Innovator in Pharmaceutical Treatments

Introduction

Delphine Behr-Roussel is a prominent inventor based in Viroflay, France. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diabetes and erectile dysfunction. Her innovative approaches have the potential to improve the quality of life for many patients.

Latest Patents

Delphine Behr-Roussel holds a patent for "Methods for treating and pharmaceutical compositions." This invention focuses on methods for improving glycemic control and treating erectile dysfunction in patients diagnosed with prediabetes, type 1 diabetes mellitus, type 2 diabetes mellitus, or metabolic syndrome. The patent details the administration of a sodium glucose co-transporter 2 (SGLT2) inhibitor to enhance treatment outcomes. Additionally, it describes a pharmaceutical composition that includes a SGLT2 inhibitor along with phosphodiesterase 5 (PDE5) inhibitors or alprostadil.

Career Highlights

Delphine is currently associated with Boehringer Ingelheim International GmbH, where she continues to advance her research and development efforts. Her work is instrumental in creating effective treatments that address critical health issues.

Collaborations

Throughout her career, Delphine has collaborated with notable colleagues, including François Giuliano and Eric Williams Mayoux. These partnerships have fostered innovation and contributed to the success of her projects.

Conclusion

Delphine Behr-Roussel is a trailblazer in the pharmaceutical industry, with her patent addressing significant health challenges. Her dedication to improving patient care through innovative treatments is commendable.